Ischemic preconditioning protects hippocampal pyramidal neurons from transient ischemic injury via the attenuation of oxidative damage through upregulating heme oxygenase-1. 2015

Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon 200-701, South Korea.

Ischemic preconditioning (IPC) provides neuroprotection against subsequent severe ischemic injury by activating specific mechanisms. In this study, we tested the hypothesis that IPC attenuates postischemic neuronal death via heme oxygenase-1 (HO-1). Animals used in this study were randomly assigned to 4 groups; sham-operated group, ischemia-operated group, IPC plus (+) sham-operated group and IPC+ischemia-operated group. IPC was induced by subjecting gerbils to 2min of ischemia followed by 1 day of recovery. A significant loss of neurons was observed in pyramidal neurons of the hippocampal CA1 region (CA1) in the ischemia-operated groups at 5 days postischemia. In the IPC+ischemia-operated groups, CA1 pyramidal neurons were well protected. The level of HO-1 protein and its activity increased significantly in the CA1 of the IPC+sham-operated group, and the level and activity was maintained in all the time after ischemia-reperfusion compared with the ischemia-operated groups. HO-1 immunoreactivity was induced in the CA1 pyramidal neurons in both IPC+sham-operated- and IPC+ischemia-operated groups. We also found that levels or immunoreactivities of superoxide anion, 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal were significantly decreased in the CA1 of both IPC+sham-operated- and IPC+ischemia-operated groups. Whereas, treatment with zinc protoporphyrin IX (a HO-1 inhibitor) into the IPC+ischemia-operated groups did not preserve the IPC-mediated increase of HO-1 and lost beneficial effects of IPC by inhibiting ischemia-induced DNA damage and lipid peroxidation. In brief, IPC protects CA1 pyramidal neurons from ischemic injury by upregulating HO-1, and we suggest that the enhancement of HO-1 expression by IPC may be a legitimate strategy for a therapeutic intervention of cerebral ischemic damage.

UI MeSH Term Description Entries
D008297 Male Males
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005849 Gerbillinae A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. Gerbils,Jird,Meriones,Psammomys,Rats, Sand,Gerbil,Jirds,Merione,Rat, Sand,Sand Rat,Sand Rats
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D051547 Heme Oxygenase-1 A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN. Hemeoxygenase 1,Heme Oxygenase 1,Oxygenase-1, Heme
D056547 CA1 Region, Hippocampal One of four subsections of the hippocampus described by Lorente de No, located furthest from the DENTATE GYRUS. CA1 Field of Hippocampus,CA1 Pyramidal Cell Area,CA1 Pyramidal Cell Layer,CA1 Stratum Pyramidale,CA1 Stratum Radiatum,Cornu Ammonis 1 Area,Hippocampal Sector CA1,Hippocampus CA1 Field,Regio Superior of Hippocampus,Stratum Radiatum, CA1,CA1 Field, Hippocampus,CA1 Stratum Radiatums,CA1, Hippocampal Sector,Field, Hippocampus CA1,Hippocampal CA1 Region,Hippocampus Regio Superior,Radiatum, CA1 Stratum,Radiatums, CA1 Stratum,Region, Hippocampal CA1,Sector CA1, Hippocampal,Stratum Pyramidale, CA1,Stratum Radiatums, CA1
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D019194 Ischemic Preconditioning A technique in which tissue is rendered resistant to the deleterious effects of prolonged ISCHEMIA and REPERFUSION by prior exposure to brief, repeated periods of vascular occlusion. (Am J Physiol 1995 May;268(5 Pt 2):H2063-7, Abstract) Ischemic Pre-Conditioning,Ischemic Pre Conditioning,Pre-Conditioning, Ischemic,Preconditioning, Ischemic

Related Publications

Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
December 2014, Critical care medicine,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
January 2014, PloS one,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
January 2015, Antioxidants & redox signaling,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
September 2006, Neuroscience letters,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
May 2012, Stroke,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
November 2004, Neurobiology of disease,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
August 2008, American journal of respiratory cell and molecular biology,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
January 1999, Transplantation proceedings,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
March 2008, Transplantation,
Jae-Chul Lee, and In Hye Kim, and Joon Ha Park, and Ji Hyeon Ahn, and Jeong-Hwi Cho, and Geum-Sil Cho, and Hyun-Jin Tae, and Bai Hui Chen, and Bing Chun Yan, and Ki-Yeon Yoo, and Jung Hoon Choi, and Choong Hyun Lee, and In Koo Hwang, and Jun Hwi Cho, and Young-Guen Kwon, and Young-Myeong Kim, and Moo-Ho Won
July 2005, Current neurovascular research,
Copied contents to your clipboard!